AbCellera Biologics, Inc. (ABCL)
13.78
+0.04
(+0.29%)
USD |
NASDAQ |
Oct 05, 16:00
13.89
+0.11
(+0.80%)
Pre-Market: 08:40
AbCellera Biologics Net Income (Quarterly) : -55.43M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -55.43M |
| March 31, 2026 | -43.16M |
| December 31, 2025 | -8.945M |
| September 30, 2025 | -57.12M |
| June 30, 2025 | -34.73M |
| March 31, 2025 | -45.62M |
| December 31, 2024 | -34.21M |
| September 30, 2024 | -51.11M |
| June 30, 2024 | -36.93M |
| March 31, 2024 | -40.61M |
| December 31, 2023 | -47.15M |
| September 30, 2023 | -28.61M |
| June 30, 2023 | -30.53M |
| Date | Value |
|---|---|
| March 31, 2023 | -40.11M |
| December 31, 2022 | -29.89M |
| September 30, 2022 | 26.62M |
| June 30, 2022 | -6.785M |
| March 31, 2022 | 168.57M |
| December 31, 2021 | 59.95M |
| September 30, 2021 | -21.38M |
| June 30, 2021 | -2.323M |
| March 31, 2021 | 117.22M |
| December 31, 2020 | 117.00M |
| September 30, 2020 | -2.692M |
| June 30, 2020 | 4.610M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| MindWalk Holdings Corp. | -4.358M |
| Repligen Corp. | 5.008M |
| Bio-Techne Corp. | 54.64M |
| Aurinia Pharmaceuticals, Inc. | 37.41M |
| BioLife Solutions, Inc. | 45.10M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 4.05M |
| Total Expenses (Quarterly) | 59.48M |
| EPS Diluted (Quarterly) | -0.1814 |
| Enterprise Value | 3.794B |
| Gross Profit Margin (Quarterly) | -116.9% |
| Profit Margin (Quarterly) | -1.37K% |
| Earnings Yield | -3.95% |
| Normalized Earnings Yield | -3.967 |